Past use of metformin is associated with increased risk of myelodysplastic syndrome development in diabetes mellitus patients: a cross-sectional study of 54,869 patients
Previous exposure to metformin amongst DM patients is associated with an increased risk for MDS development later in life. This is a preliminary, cross-sectional study that show that larger studies in variable MDS patient populations are warranted.
Authors
- Tamer Hellou (ORCID: https://orcid.org/0009-0009-2179-3963)
- Reut Kassif Lerner (ORCID: https://orcid.org/0000-0003-1018-1071)
- Gad Segal (ORCID: https://orcid.org/0000-0002-3851-3245)
- Ahlam Athamna
- Aviv Philip Goncharov (ORCID: https://orcid.org/0009-0001-1811-3535)
- Shir Portugez
- Guy Dumanis
- Aya Berman (ORCID: https://orcid.org/0000-0001-7107-0549)
- A. Stern
- Ekram Nimer
- Eden Trodler
- Imanuel Carlebach
- Omer Kahlon
- Maysan Abu Jwella
Institutions
- Tel Aviv University (IL)
- Medical University of Silesia (PL)
- Sheba Medical Center (IL)
- Geha Mental Health Center (IL)
- Ariel University (IL)
- Palacký University Olomouc (CZ)
- Kharkiv National Medical University (UA)
Publication Details
- Journal
- BMC Pharmacology and Toxicology
- Published
- 2025-02-27
- DOI
- https://doi.org/10.1186/s40360-025-00882-7
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00